Painreform
Yahoo Finance • last month
PRF Technologies’ GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization
PRF Technologies Ltd. IEA projects global data center electricity consumption to roughly double to 950 TWh by 2030, with consumption from AI-focused data centers expected to triple Company believes GridFeed's existing AI optimization eng... Full story
Yahoo Finance • 3 months ago
PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data
TEL AVIV, Israel, July 08, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced that its DeepSolar business unit has completed an initial validation phase for DeepSolar Predict™, the Comp... Full story
Yahoo Finance • 5 months ago
PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study
TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”), a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain... Full story
Yahoo Finance • 7 months ago
PainReform reports FY results
* PainReform press release [https://seekingalpha.com/pr/20453781-prf-technologies-provides-year-end-2025-business-update-highlighting-strategic-progress] (PRFX [https://seekingalpha.com/symbol/PRFX]): FY * Net loss for the year ended D... Full story
Yahoo Finance • 11 months ago
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy
TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced, through its pharmaceutical division, the commencement of its development plan for OcuRing™-K, LayerBio’s patented, drop-less, intraoperat... Full story
Yahoo Finance • 11 months ago
PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
PainReform Ltd TEL AVIV, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, its solar energy business unit developing next-generation AI-driven solar analytics, was recently featured... Full story
- NVDA
Mentioned:
Yahoo Finance • last year
PainReform Provides Business Update for the Six Months Ended June 30, 2025
TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologi... Full story
Yahoo Finance • last year
PainReform/DeepSolar Accepted into NVIDIA Connect Program
TEL AVIV, Israel, Aug. 19, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, PainReform’s solar energy business unit developing next-generation AI-driven solar analytics, has been accepted into the... Full story
- NVDA
Mentioned:
Yahoo Finance • last year
PainReform acquires majority stake in LayerBio to advance eye surgery drug
TEL AVIV - PainReform Ltd. (NASDAQ:PRFX), a micro-cap biotech company with a market capitalization of $2.7 million and currently trading at $1.35 per share, has completed its previously announced investment in LayerBio, Inc., acquiring a m... Full story
- T
Mentioned:
Yahoo Finance • last year
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System
TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio, Inc., a privately held Boston-based... Full story
Yahoo Finance • 2 years ago
PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization Market
TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion i... Full story
Yahoo Finance • 2 years ago
PainReform Provides Year-End Business Update
TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of the... Full story
Yahoo Finance • 2 years ago
PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
TEL AVIV, Israel, March 05, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announ... Full story
Yahoo Finance • 3 years ago
PainReform Provides Business Update for the Third Quarter of 2023
TEL AVIV, Israel, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provide... Full story
Yahoo Finance • 3 years ago
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary
TEL AVIV, Israel, Sept. 07, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announ... Full story
Yahoo Finance • 3 years ago
PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City
TEL AVIV, Israel, Sept. 05, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announ... Full story
Yahoo Finance • 3 years ago
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement
TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announc... Full story
Yahoo Finance • 3 years ago
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
TEL AVIV, Israel, July 12, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announc... Full story
Yahoo Finance • 3 years ago
PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21st
TEL AVIV, Israel, June 15, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announc... Full story